on prostate cancer
Zodiac Pharmaceutical Products has recently
launched a medicament able to reduce the production of testosterone
which prevents the patients from having an increase in the prostate
tumor. According to the company, they expect to sell about R$ 1.7
million of the product in 2007.
SEM Medicament grows 50%
Gerovital, by EMS-Sigma Farma, had a sales
increase of 50% between 2005 and 2006. Thst great result is due
to a new company´s strategy for the product, which is composed
by calcium, ferrous sulfate, fosfate and Ginseng.
Roche Presidente wins a prize
Ernest Egli, a Swiss with Brazilian citizenship,
was praised with the title Cidadão Paulistano (Citizen from
São Paulo), offered by the Municipal Chamber of Sao Paulo.
He graduated in Business Administration and Economy and has doctorate
in Marketing from St Gallen University. Egli is graduated in Strategic
Marketing from Harvard Business School in the USA.
Zambon celebrates 100
Zambon Laboratories celebrated the company´s
hundredth anniversary by announcing that they will invest in the
Brazilian branch in the next few years. Such strategy is part of
the 30 Tutti Challenge Campaign that intends to double Zambon income
by 2008 besides reaching the 30ª place in the national ranking
of the pharmaceutical industry.
Cristália´s New Presentation
The Prosigne, botulinum toxin type A from Cristália,
can now be found in 50U. According to the company, this new presentation
has a reduced volume and the physician does not need to have two
or three patients at least to apply it.
Sandoz prizes suppliers
Sandoz, patent-free medicaments division at
Novartis Group, promoted the 11ª edition of the Suppliers Qualification
System (SQS). Eighty companies tried it although only twenty two